Engerix-b 20 MCG/ML syrnml
Ended Awarded
- Contract number
- SPE2DB25FLRHH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,752
Award facts
- Contract value 100% obligated
- $1,751.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,751.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. ENGERIX-B is a hepatitis B vaccine commonly procured by the federal government to support military and veteran healthcare initiatives.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive pharmaceutical supply agreements with the Defense Logistics Agency. The company's DLA Troop Support Medical contract functions as a global pharmaceutical support vehicle enabling delivery of a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order for vaccine supplies reflects AmerisourceBergen's ongoing role as a preferred pharmaceutical provider for the Defense Health Agency and broader federal healthcare systems through competitively awarded, firm fixed-price contract mechanisms.
Quick answers
Who was awarded contract SPE2DB25FLRHH?
SPE2DB25FLRHH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FLRHH worth?
The government has obligated $1,752 on SPE2DB25FLRHH.
Is contract SPE2DB25FLRHH an order under another contract?
Yes. SPE2DB25FLRHH is a delivery order under SPE2DB25D3002, an indefinite delivery contract.
Was contract SPE2DB25FLRHH competed?
The extent of competition for SPE2DB25FLRHH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award